Fate Therapeutics
FATE
FATE
123 hedge funds and large institutions have $1.07B invested in Fate Therapeutics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
9% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 45
31% less call options, than puts
Call options by funds: $4.55M | Put options by funds: $6.59M
Holders
123
Holding in Top 10
5
Calls
$4.55M
Puts
$6.59M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$11.5M | |
| 3 | +$9.88M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.79M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.84M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$6.48M | |
| 3 | -$6.15M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$6.15M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.83M |